Modulation of migration and Ca2 signaling in retinal pigment epithelium cells by recombinant human CTGF

Current Eye Research

Volumn 34, Issue 10, 2009, Pages 852-862

  Guo, Chang Mei ^a   Wang, Yu Sheng ^a   Hu, Dan ^a   Han, Quan Hong ^a   Wang, Jing Bo ^a   Hou, Xu ^a   Hui, Yan Nian ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Ca2+ signaling; Cell migration; Connective tissue growth factor; Proliferative vitreoretinopathy; Retinal pigment epithelial cell; Wound healing

Indexed keywords

8 BROMO CYCLIC AMP; CALCIUM ION; CONNECTIVE TISSUE GROWTH FACTOR; DEXAMETHASONE; FLUO 3; RECOMBINANT HUMAN CONNECTIVE TISSUE GROWTH FACTOR; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CTGF PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL MIGRATION; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; DRUG MECHANISM; EXTRACELLULAR CALCIUM; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN SITU HYBRIDIZATION; IN VITRO STUDY; MODULATION; PIGMENT CELL; PRIORITY JOURNAL; VITREORETINOPATHY; WESTERN BLOTTING; WOUND HEALING; ADULT; CELL MOTION; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PIGMENT EPITHELIUM;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADULT; ANTI-INFLAMMATORY AGENTS; CALCIUM SIGNALING; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CONNECTIVE TISSUE GROWTH FACTOR; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HUMANS; RECOMBINANT PROTEINS; RETINAL PIGMENT EPITHELIUM; VITREORETINOPATHY, PROLIFERATIVE; WOUND HEALING;

EID: 70449507402     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713680903128935     Document Type: Article

References (55)

1. Campochiaro PA. Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol. 1997;115:237-248.
2. Pastor JC. Proliferative vitreoretinopathy: An overview. Surv Ophthalmol. 1998;43:3-18.
3. Han QH, Hui YN, Du HJ, et al. Migration of retinal pigment epithelial cells in vitro modulated by monocyte chemotactic protein-1: Enhancement and inhibition. Graefes Arch Clin Exp Ophthalmol. 2001;239:531-538.
4. Blom IE, Goldschmeding R, Leask A. Gene regulation of connective tissue growth factor: New targets for antifibrotic therapy? Matrix Biol. 2002;21:473-482.
5. Moussad EE, Brigstock DR. Connective tissue growth factor: What's in a name? Mol Genet Metab. 2000;71:276-292.
6. Bradham DM, Igarashi A, Potter RL, et al. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRCinduced immediate early gene product CEF-10. J Cell Biol. 1991;114:285-294.
7. Hinton DR, He S, Jin ML, et al. Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye. 2002;16:422-428.
8. Cui JZ, Chiu A, Maberley D, et al. Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy. Eye. 2007;21:200-208.
9. He S, Chen Y, Khankan R, et al. Connective tissue growth factor as a mediator of intraocular fibrosis. Invest Ophthalmol Vis Sci. 2008;49:4078-4088.
10. Meyer P, Wunderlich K, Kain HL, et al. Human connective tissue growth factor mRNA expression of epiretinal and subretinal fibrovascular membranes: A report of three cases. Ophthalmologica. 2002;216:284-291.
11. Polansky JR, Weinreb R. Steroid as anti-inflammatory agents. Ocul Pharmacol. 1984;69:461-538.
12. Hui YN, Liang HC, Cai YS, et al. Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages. Grafes Arch Clin Exp Ophthalmol. 1993;231:109-114.
13. Hackett S, Friedman Z, Campochiaro PA. Cyclic 3',5'- adenosine monophosphate modulates retinal pigment epithelial cell migration in vitro. Arch Ophthalmol. 1986;104:1688-1692.
14. Huang W, Wang L, Yuan M, et al. Adrenomedullin affects two signal transduction pathways and the migration in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2004;45:1507-1513.
15. Wang YS, Yan M. Visible light damage in the primary cultured human retinal pigment epithelial cells. Chin J Ocul Fundus Dis. 1996;12:174-176.
16. 2+ signaling in human polymorphonuclear cells. Immunol Lett. 2003;89:161-165.
17. He S, Jin ML, Worpel V, et al. A role for connective tissue growth factor in the pathogenesis of choroidal neovascularization. Arch Ophthalmol. 2003;121:1283-1288.
18. Igarashi A, Okochi H, Bradham DM, et al. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell. 1993;4:637-645.
19. Dammeier J, Beer HD, Brauchle M, et al. Dexamethasone is a novel potent inducer of connective tissue growth factor expression. Implications for glucocorticoid therapy. J Biol Chem. 1998;273:18185-18190.
20. Yamanaka O, Saika S, Ikeda K, et al. Connective tissue growth factor modulates extracellular matrix production in human subconjunctival fibroblasts and their proliferation and migration in vitro. Jpn J Ophthalmol. 2008;52:8-15.
21. Yang YM, Wu XY, Du LQ. The role of connective tissue growth factor, transforming growth factor, and Smad signaling pathway during corneal wound healing. Zhonghua Yan Ke Za Zhi. 2006;42:918-924.
22. Suzuma K, Naruse K, Suzuma I, et al. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem. 2003;275:40725-40731.
23. Pawar S, Kartha S, Toback FG. Differential gene expression in migrating renal epithelial cells after wounding. J Cell Physiol. 1995;165:556-565.
24. Matsuda S, Gomi F, Katayama T, et al. Induction of connective tissue growth factor in retinal pigment epithelium cells by oxidative stress. Jpn J Ophthalmol. 2006;50:229-234.
25. Segarini PR, Nesbitt JE, Li D, et al. The low-density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem. 2001;276:40659-40667.
26. Gao R, Brigstock DR. Low-density lipoprotein receptorrelated protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res. 2003;27:214-220.
27. Singh S, Zheng JJ, Peiper SC, et al. Gene expression profile of ARPE-19 during repair of the monolayer. Graefes Arch Clin Exp Ophthalmol. 2001;239:946-951.
28. Yoshida A, Elner SG, Bian ZM, et al. Induction of interleukin-8 in human retinal pigment epithelial cells after denuding injury. Br J Ophthalmol. 2001;85:872-876. (Pubitemid 32662091)
29. Schwab JM, Beschorner R, Nguyen TD, et al. Differential cellular accumulation of connective tissue growth factor defines a subset of reactive astrocytes, invading fibroblasts, and endothelial cells following central nervous system injury in rats and humans. J Neurotrauma. 2001;18:377-388.
30. Spliet WG, Aronica E, Ramkema M, et al. Increased expression of connective tissue growth factor in amyotrophic lateral sclerosis human spinal cord. Acta Neuropathol (Berl). 2003;106:449-457.
31. Ito Y, Aten J, Bende RJ, et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int. 1998;53:853-861.
32. Kanemoto K, Usui J, Tomari S, et al. Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis. Lab Invest. 2003;83:1615-1625.
33. Pfeffer BA, Flanders KC, Guerin CJ, et al. Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid, and vitreous of the monkey eye. Exp Eye Res. 1994;59:323-333.
34. Bochaton-Piallat ML, Kapetanios AD, Donati G, et al. TGF-beta I, TGF-beta receptor II, and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest Ophthalmol Vis Sci. 2000;41:2336-2342.
35. Lee SC, Kwon OW, Seong GJ. Epitheliomesenchymal transdifferentiation of cultured RPE cells. Ophthalmic Res. 2001;33:80-89.
36. Babic AM, Chen CC, Lau LF. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin aαvβ3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol. 1999;19:2958-2966.
37. Fan WH, Pech M, Karnovsky MJ. Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro. Eur J Cell Biol. 2000;79:915-923.
38. Gao R, Brigstock DR. A novel integrin aα5β1 binding domain in module 4 of connective tissue growth factor (CCN2/ CTGF) promotes adhesion and migration of activated pancreatic stellate cells. Gut. 2006;55:856-862.
39. Hoshijima M, Hattori T, Inoue M, et al. CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin W5V1. FEBS Lett. 2006;580:1376-1382.
40. Blom IE, Dijk AJV, Wieten L, et al. In vitro evidence for differential involvement of CTGF, TGFβ, and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant. 2001;16:1139-1148.
41. Fan WH, Karnovsky MJ. Increased MMP-2 expression in connective tissue growth factor over-expression vascular smooth muscle cells. J Biol Chem. 2002;277: 9800-9805.
42. Kita T, Hata Y, Miura M, et al. Functional characteristics of connective tissue growth factor on vitreoretinal cells. Diabetes. 2007;56:1421-1428.
43. Chen CC, Chen N, Lau LF. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem. 2001;276:10443-10452.
44. Kuiper EJ, de Smet MD, van Meurs JC, et al. Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye. Arch Ophthalmol. 2006;124:1457-1462.
45. Li CL, Martinez V, He B, et al. A role for CCN3 (NOV) in calcium signaling. Mol Pathol. 2002;55:250-261.
46. Schwab A. Function and spatial distribution of ion channels and transporters in cell migration. Am J Physiol Renal Physiol. 2001;280:F739-F747.
47. Smith-Thomas LC, Haycock JW, Metcalfe R, et al. Involvement of calcium in retinal pigment epithelial cell proliferation and pigmentation. Curr Eye Res. 1998;17:813-822.
48. Smith-Thomas LC, Richardson PS, Rennie IG, et al. Influence of pigment content, intracellular calcium, and cyclic AMP on the ability of human retinal pigment epithelial cells to contract collagen gels. Curr Eye Res. 2000;21: 518-529.
49. Lombet A, Planque N, Bleau AM, et al. CCN3 and calcium signaling. Cell Commun Signal. 2003;1:1-10.
50. Hoffmann S, Spee C, Erren M. Effect of the calciumantagonist verapamil on the serum induced proliferation of RPE cells in vitro. Invest Ophthamol Vis Sci. 1996;37:S389
51. Rubsamen PE, Cousins SW. Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy. Retina. 1997;17:44-50.
52. Lee JH, Kim SJ, Chung H. The effect of subtenon injection of methylprednisolone acetate on the breakdown of blood retinal barrier after cryotherapy. Korean J Ophthalmol. 1995;9:1-6.
53. Schuchmann S, Wiontzek M, Burmester GR, et al. Modulation of intracellular calcium signaling and mitochondrial function in cultured osteoblastic cells by dexamethasone and celecoxib during mechanical stimulation. Clin Exp Rheumatol. 2004;22:184-196.
54. 2+ induced by antigen. Biochim Biophys Acta. 1990;1051:203-206.
55. Han JZ, Lin W, Chen YZ. Inhibition of ATP-induced calcium influx in HT4 cells by glucocorticoids: Involvement of protein kinase A. Acta Pharmacol Sin. 2005;26:199-204.